Products & Services
A portfolio built on two technology platforms, covering 15 testing application categories; 165 devices are listed in the Notified Body confirmation letter (TÜV Rheinland, NB 0197), with a transition pathway under Regulation (EU) 2024/1860.
Technology platforms
Isothermal amplification + CRISPR (RAA + CRISPR)
Proprietary molecular POCT platform: RAA rapidly amplifies target nucleic acids at a constant temperature, and the CRISPR-Cas system specifically recognizes the target sequence and produces a detectable signal; switching primers and crRNA extends the platform to different pathogens.
- Time-to-result: 20–30 minutes
- Used to complete the development of reagents for all four dengue serotypes
Lateral-flow rapid tests
Rapid-test lines covering infectious disease antigens/antibodies, inflammation and cardiac markers, coagulation and metabolic indicators for primary care and field settings.
- Room-temperature storage and transport
- Single-analyte and multi-panel formats
Master-distribution portfolio (165 products)
As the master distributor of the Kangsheng Yanxuan system, Jingzhun Bio has been granted sales authorization for 165 products (devices for which no Notified Body certificate was required in the IVDD era, listed in the TÜV Rheinland NB 0197 confirmation letter). The full product catalog (product names, Basic UDI-DI, IVDR classification and transition end-points) is available on the Kangsheng Yanxuan website:
View product catalog on kangshengyanxuan.com →
Services and partnership
Product supply
Reliable supply and supply-chain collaboration for distributors and laboratory partners, with regional portfolio configuration support.
Technical support and training
Product training, workflow guidance and responsive after-sales technical support to help partners deploy efficiently.
For quotations or distribution inquiries, please visit the contact page.